Use of neoadjuvant and postoperative chemotherapy with surgical resection of colorectal cancer hepatic metastases

Research output: Contribution to journalArticle

1 Citation (Scopus)

Abstract

Hepatic metastases from colorectal cancer are common in patients presenting with an initial diagnosis of metastatic disease or at the time of recurrence. For many patients, the liver may be the only site of meta-static disease. Surgical resection of the metastases may provide long-term benefit, but their size, number, or location may limit the possibility of a resection. A growing body of literature from both retrospective patient series and prospective clinical trials suggests that preop-erative therapy may enhance the chance for resection and improve outcome for initially unresectable or not optimally resectable metastases. In selected situations, neoadjuvant chemotherapy also may be beneficial for patients with potentially resectable metastases. Further trials are needed to refine the guidelines for preopera-tive and perioperative chemotherapy.

Original languageEnglish (US)
Pages (from-to)100-105
Number of pages6
JournalCurrent Colorectal Cancer Reports
Volume4
Issue number2
DOIs
StatePublished - Apr 2008

Fingerprint

Colorectal Neoplasms
Neoplasm Metastasis
Drug Therapy
Liver
Clinical Trials
Guidelines
Recurrence
Therapeutics

ASJC Scopus subject areas

  • Oncology
  • Gastroenterology
  • Hepatology

Cite this

@article{464c812d296e4c84898e09e61b24adf5,
title = "Use of neoadjuvant and postoperative chemotherapy with surgical resection of colorectal cancer hepatic metastases",
abstract = "Hepatic metastases from colorectal cancer are common in patients presenting with an initial diagnosis of metastatic disease or at the time of recurrence. For many patients, the liver may be the only site of meta-static disease. Surgical resection of the metastases may provide long-term benefit, but their size, number, or location may limit the possibility of a resection. A growing body of literature from both retrospective patient series and prospective clinical trials suggests that preop-erative therapy may enhance the chance for resection and improve outcome for initially unresectable or not optimally resectable metastases. In selected situations, neoadjuvant chemotherapy also may be beneficial for patients with potentially resectable metastases. Further trials are needed to refine the guidelines for preopera-tive and perioperative chemotherapy.",
author = "Alberts, {Steven Robert}",
year = "2008",
month = "4",
doi = "10.1007/s11888-008-0017-y",
language = "English (US)",
volume = "4",
pages = "100--105",
journal = "Current Colorectal Cancer Reports",
issn = "1556-3790",
publisher = "Springer Science + Business Media",
number = "2",

}

TY - JOUR

T1 - Use of neoadjuvant and postoperative chemotherapy with surgical resection of colorectal cancer hepatic metastases

AU - Alberts, Steven Robert

PY - 2008/4

Y1 - 2008/4

N2 - Hepatic metastases from colorectal cancer are common in patients presenting with an initial diagnosis of metastatic disease or at the time of recurrence. For many patients, the liver may be the only site of meta-static disease. Surgical resection of the metastases may provide long-term benefit, but their size, number, or location may limit the possibility of a resection. A growing body of literature from both retrospective patient series and prospective clinical trials suggests that preop-erative therapy may enhance the chance for resection and improve outcome for initially unresectable or not optimally resectable metastases. In selected situations, neoadjuvant chemotherapy also may be beneficial for patients with potentially resectable metastases. Further trials are needed to refine the guidelines for preopera-tive and perioperative chemotherapy.

AB - Hepatic metastases from colorectal cancer are common in patients presenting with an initial diagnosis of metastatic disease or at the time of recurrence. For many patients, the liver may be the only site of meta-static disease. Surgical resection of the metastases may provide long-term benefit, but their size, number, or location may limit the possibility of a resection. A growing body of literature from both retrospective patient series and prospective clinical trials suggests that preop-erative therapy may enhance the chance for resection and improve outcome for initially unresectable or not optimally resectable metastases. In selected situations, neoadjuvant chemotherapy also may be beneficial for patients with potentially resectable metastases. Further trials are needed to refine the guidelines for preopera-tive and perioperative chemotherapy.

UR - http://www.scopus.com/inward/record.url?scp=78650337575&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=78650337575&partnerID=8YFLogxK

U2 - 10.1007/s11888-008-0017-y

DO - 10.1007/s11888-008-0017-y

M3 - Article

AN - SCOPUS:78650337575

VL - 4

SP - 100

EP - 105

JO - Current Colorectal Cancer Reports

JF - Current Colorectal Cancer Reports

SN - 1556-3790

IS - 2

ER -